Clinical Research Trials

Spokane Eye Clinic added a Clinical Research department in January, 2011.  Currently we are involved in 11 clinical studies.  Here is a listing of clinical trials currently open for recruitment.  If you have any questions or wish to discuss participation, please call our research coordinator Eileen at 623-9768.

More information may be found by clicking your mouse on the links below.

Inherited Eye Disease

EyeGENE

This study is sponsored by the National Eye Institute (NEI)

Diabetic Eye Disease:

We are members of DRCR.net - Diabetic Retinopathy Clinical Research Network (DRCRnet)

http://drcrnet.jaeb.org/Studies.aspx  and are currently looking for patients with swelling due to diabetic changes in their eye for two studies:

Treatment for Central-Involved Diabetic Macular Edema in eyes with very good visual acuity

https://clinicaltrials.gov/ct2/show/NCT01909791?term=DRCR&rank=3

And a study sponsored by Allegro

A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate (ALG-1001) as Compared to Avastion and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema

https://clinicaltrials.gov/ct2/show/NCT02348918?term=DME+Allegro&rank=1

Pediatrics:

We are members of the Pediatric Eye Disease Investigator Group (PEDIG)

http://pedig.jaeb.org/ViewPage.aspx?PageName=Home_Page

and are recruiting for the following studies:

ATS18 - Study of Binocular Computer Activities for Treatment of Amblyopia (lazy eye)

https://clinicaltrials.gov/ct2/show/NCT02200211?term=ATS18+-+Study+of+Binocular+Computer+Activities+for+Treatment+of_Amblyopia&rank=1

Wet Macular Degeneration:

We are enrolling patients with new diagnosis of wet AMD (Age-related Macular Degeneration)

Efficacy and Safety of RTH258 Versus Afibercept

https://clinicaltrials.gov/ct2/show/NCT02307682?term=alcon+wet+AMD&rank=15

Dry Macular Degeneration

We are enrolling patients with Dry AMD (Age-related Macular Degeneration) present in both eyes.

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Patients with Geographic Atrophy Secondary to Age-Related macular Degeneration (CHROMA)

https://clinicaltrials.gov/ct2/show/NCT02247479?term=Chroma&rank=1